Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SOUND: Bronchodilators and Lung Mechanics in COPD
NCT06825013Phase 4Recruiting
- Start
- Nov 2024
- Primary completion
- Jan 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of salbutamol, ipratropium bromide in chronic obstructive pulmonary disease (COPD). Started Nov 2024; status: recruiting.
02
Drugs
salbutamolipratropium bromide
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT06825013.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06825013.